Results 141 to 150 of about 68,999 (229)

Recurrence rates and risk factors in obscure gastrointestinal bleeding

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Obscure gastrointestinal bleeding (OGIB), defined in 2010, involves bleeding from the GI tract that remains unexplained after standard diagnostic procedures. OGIB, which accounts for about 5% of all GI bleeds, poses diagnostic and management challenges, particularly due to the anatomical features of the small intestine.
Sachiyo Onishi, Takuji Iwashita, Yukari Tezuka, Kentaro Kojima, Jun Takada, Masaya Kubota, Takashi Ibuka, Masahito Shimizu   +7 more
wiley   +1 more source

Somatostatin triggers local cAMP and Ca²⁺ signaling in primary cilia to modulate pancreatic β-cell function. [PDF]

EMBO J
Nilsson CI, Dumral Ö, Sanchez G, Xie B, Müller A, Solimena M, Ren H, Idevall-Hagren O.   +7 more
europepmc   +1 more source

Opiate antagonistic properties of an octapeptide somatostatin analog. [PDF]

, 1982
R. Maurer, Beat H. Gaehwiler, H.‐H. BUESCHER, Ronald C. Hill, D. Roemer   +4 more
openalex   +1 more source

Profound gastric mucosal changes and severe rebound acid hypersecretion after long‐term Vonoprazan use: A case report

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Vonoprazan is a novel acid blocker with greater potency than proton pump inhibitors. A Japanese study reported no significant safety concerns over 5 years of Vonoprazan use; however, elevated serum gastrin and increased parietal cell and foveolar hyperplasia were observed, and long‐term safety data beyond 5 years are limited.
Hiroko Suda, Sachi Eto, Koichi Sakurai
wiley   +1 more source

Insight into the Potential of Somatostatin Vaccination with Goats as a Model: From a Perspective of the Gastrointestinal Microbiota. [PDF]

Animals (Basel)
Zhang X, Chen J, Zhang S, Wei B, Han Y, Zhao Z.   +5 more
europepmc   +1 more source

Identification and Exploration of Immunity‐Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics

Immunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
We used a variety of methods to identify biomarkers and compounds of Alzheimer's disease, providing new insights into the clinical research transformation of Alzheimer's disease. ABSTRACT Background Recent research highlights the immune system's role in AD pathogenesis and promising prospects of natural compounds in treatment.
Pengpeng Liang, Yale Wang, Jiamin Liu, Hai Huang, Yue Li, Jinhua Kang, Guiyun Li, Hongyan Wu   +7 more
wiley   +1 more source

Molecular identification of somatostatin family in tilapia and the effect of food intake on pss2 and sstr3a. [PDF]

Sci Rep
Cai R, Zhang J, Yu X, Yu Y, Liao Z, Li W.   +5 more
europepmc   +1 more source

Activating Striatal Parvalbumin Interneurons to Alleviate Chemotherapy‐Induced Muscle Atrophy

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background Cisplatin is a widely used chemotherapeutic agent for treating solid tumours. Still, it induces severe side effects, including muscle atrophy. Understanding the mechanisms of cisplatin‐induced muscle loss and exploring potential therapeutic strategies are essential.
Jun Hu, Jingyuan Liu, Yuqing Yan, Ziyu Shen, Junlong Sun, Yongjun Zheng   +5 more
wiley   +1 more source

Real-time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes. [PDF]

Acta Physiol (Oxf)
Yang M, Mandal K, Södergren M, Dumral Ö, Winroth L, Tengholm A.   +5 more
europepmc   +1 more source

The interaction of Vasoactive Intestinal Polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas [PDF]

, 1980
J Szecówka, Elvi Sandberg, S. Efendić
openalex   +1 more source